H.C. Wainwright initiated coverage on Glaukos with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for GKOS
Across the 15 sessions after earlier GKOS headlines, the stock closed higher 11 times and lower 4 times, with a median move of 3.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | GKOS | SPY |
|---|---|---|---|
| Jun 25, 2026 | Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis | +3.5% | +0.1% |
| May 12, 2026 | Glaukos Announces Participation in Upcoming Investor Conferences | +0.7% | -0.2% |
| Apr 30, 2026 | Glaukos Announces First Quarter 2026 Financial Results | +22.8% | +1.0% |
| Apr 16, 2026 | Glaukos Announces the Release of its 2025 Sustainability Reportand 1 other headline that session | +0.5% | +0.2% |
| Apr 8, 2026 | Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29 | +3.1% | +2.5% |
| Mar 19, 2026 | Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care | -1.1% | -0.2% |
Quantisnow market dataNYSE
GKOS
Glaukos Corporation
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2015
Get push alerts for GKOS
Full GKOS profile on Quantisnow Follow GKOS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time